asa glp-1 agonists πΈ Should RAs be continued preprocedurally? πΈ Who should stop a GLP-1 RA preoperatively? πΈ Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f Glucagon-Like Peptide-1 Agonists and General
Description
Karnsund, S., Lo, B., Bendtsen, F., Holm, J

Under the brand name Ozmepic, it's approved to treat type 2 diabetes, while under the brand name Wegovy, it's approved for weight loss

Inzucchi, S

One phase 2 trial looking at whether GLP-1s could reduce the use of opioids in people with opioid use disorder has started recruiting participants

Among 26,944 adults with type 2 diabetes, there were 1848 individuals in the GLP-1RA group, 5034 in the SGLT-2i group, 4813 in the insulin group and 15,249 in the miscellany group (Table 1)
